Lysosomal storage diseases: how COVID-19 has shaped delivery of care

Webinar • EuroAPI UK

About the CPD course

The UK and Ireland had a high incidence of COVID-19 which impacted the Lysosmal Disorders Community. The webinar provides learnings and insights for the future. The chairperson with be Professor Derralynn Hughes from Royal Free Hospital in London; she will introduce the webinar and also deliver a short 20min presentation on " How does the management of LSD's during COVID-19 inform future service design". There will be a second 20 min presentation from Liz Morris Clinical Nurse Specialist at Addenbrookes Hospital & Amanda Daniel Clinical Nurse Specialist at University Hospitals of Wales on the patient’s perspective.

CPD Provider

EuroAPI UK

View Profile

Send an enquiry

Full Name*

Email Address*

Contact Number*

Industry*

Your Enquiry*

By submitting this form, you consent to CPD sending you email regarding your application.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EuroAPI UK

Founded in 1981 in Boston, Massachusetts, EuroAPI evolved from a tiny start-up to one of the world's leading biotech companies, with nearly 10,000 employees and operations in every region of the globe. Acquired by Sanofi in 2011, EuroAPI UK now benefits from the reach and resources of one of the world’s largest pharmaceutical companies, with a shared commitment to improving the lives of patients.